Alessio Gordon Naccarati, PhD

Naccarati has been head of the Genetic and Molecular Epidemiology Unit at the Italian Institute for Genomic Medicine (IIGM) in Turin, Italy since 2019. Previously, he has worked as senior researcher in the same group (2011-2019), as well as at the Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague (2006-2011), where he also worked as a post-doctoral fellow (2003-2005). He got his PhD in Human Molecular Genetics from the University of Pisa, Italy in 2003.

Naccarati’s research focuses on colon cancer, cancer microbiome, non-coding RNA, RNA sequencing, and the effect of lifestyle and diet on disease. He is currently the PI of a project entitled Fecal non-coding RNA markers for a precision medicine approach: how they reflect colorectal cancer onset and progression, funded by AIRC Associazione Italiana per la Ricerca sul Cancro.

Barbara Pardini, PhD

Pardini is a senior researcher in the laboratory of Alessio Naccarati at the Genetic and Molecular Epidemiology Unit, Italian Institute for Genomic Medicine in Turin, Italy, where she has been located since 2011. Previously, she was a post-doctoral fellow at the Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague (2007-2011), and she got her PhD in Microbiology and Genetics from the University of Pisa, Italy in 2007. Pardini works together with Naccarati on research related to colon cancer, cancer microbiome, non-coding RNA, RNA sequencing, and the effect of lifestyle and diet on disease.

Kay Oliver Schink

Schink works as an associate professor at the Center for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo. In his research, he utilizes advanced imaging techniques to study intracellular events like autophagy, macropinocytosis, and membrane dynamics at high resolution.

MVDr. Eva Dražanová, PhD

Dražanová works as an associate professor in Brno, Czech Republic. Her research focuses on ultra-high field magnetic resonance applications for research in the field of preclinical psychopharmacology. Her presentation at EHRC 2024 will inform participants about methods in use in preclinical psychopharmacological research using an ultra-high field MRI system. The main focus will be the utilization of perfusion MRI protocols in rat models of psychopathology and psychopharmacological interventions.